Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 5 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A
6(100.0%)
6Total
N/A(6)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials
NCT06347380Not ApplicableCompleted

Usability Study of the FemPulse System

Role: lead

NCT03784170Not ApplicableCompleted

FemPulse Therapy for Overactive Bladder in Women

Role: lead

NCT06885099Not ApplicableCompleted

Ease of Use Study of the FemPulse System

Role: lead

NCT07195656Not ApplicableRecruiting

Evaluation of a Non-Implanted Electrical Stimulation Device for Overactive Bladder (OAB)

Role: lead

NCT04001426Not ApplicableCompleted

Pilot Phase for an Acute Evaluation of a Non-Implantable Electrical Continence Device

Role: lead

NCT03874637Not ApplicableCompleted

FemPulse Therapy First-in-Human Experience

Role: lead

All 6 trials loaded